Article
A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
6 Aug 2024
Abstract excerpt
Circulating tumor cells (CTCs) have potential as diagnostic, prognostic, and predictive biomarkers in solid tumors. Despite Food and Drug Administration (FDA) approval of CTC devices in various cancers, the rarity and heterogeneity of CTCs in lung cancer make them technically challenging to isolate and analyze, hindering their clinical integration. Establishing a consensus through comparative analysis of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
